Morning Briefing
Summaries of health policy coverage from major news organizations
Major Gene Editing Breakthrough Raises Concerns About Ethics Of 'Designer Babies'
Scientists for the first time have successfully edited genes in human embryos to repair a common and serious disease-causing mutation, producing apparently healthy embryos, according to a study published on Wednesday. The research marks a major milestone and, while a long way from clinical use, it raises the prospect that gene editing may one day protect babies from a variety of hereditary conditions. (Belluck, 8/2)
This is the first time gene editing on human embryos has been conducted in the聽United States. Researchers聽said in interviews this week聽that they聽consider their work very basic. The embryos were allowed to grow for only a few days, and there was never any intention to implant them to create a pregnancy. But they also acknowledged that they will continue to move forward with the science, with the聽ultimate goal of being able to 鈥渃orrect鈥 disease-causing genes in embryos that will develop into babies. (Cha, 8/2)
Scientists鈥 ultimate goal is to fix gene mutations that lead to debilitating or fatal diseases, and to prevent the propagation of those mutations to future generations. Study leader Shoukhrat Mitalipov, a biologist at OHSU, said the new findings might correct genetic variants that can cause breast and ovarian cancer, cystic fibrosis and muscular dystrophy in those who inherit them. (Healy, 8/2)
"Potentially, we're talking about thousands of genes and thousands of patients," says Paula Amato, an associate professor of obstetrics and gynecology at Oregon Health & Science University in Portland. She was a member of the scientific team from the U.S., China and South Korea. (Stein, 8/2)
The study results raise ethical questions because they involve changes to the human germ-line, the genes of sperm, eggs or embryos. Scientists and bioethicists have called for caution in editing the germ-line because such changes would not only alter the individual but also be passed to future generations. (Marcus, 8/2)
Creating 鈥渄esigner babies鈥 with a revolutionary new genome-editing technique would be extremely difficult, according to the first U.S. experiment that tried to replace a disease-causing gene in a viable human embryo. Partial results of the study had聽leaked out last week, ahead of its publication in Nature on Wednesday, stirring critics鈥 fears that genes for desired traits 鈥 from HIV resistance to strong muscles 鈥 might soon be easily slipped into embryos. In fact, the researchers found the opposite: They were unable to insert a lab-made gene. (Begley, 8/2)
For the first time in the U.S., a human embryo has been successfully edited to correct an inherited condition. ... But the milestone raises significant scientific and ethical questions. (Sreenivasen, 8/2)